HARROW HEALTH INC's ticker is HROW and the CUSIP is 415858109.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $52,206 | -79.2% | 3,633 | -72.4% | 0.00% | -75.0% |
Q2 2023 | $250,528 | +610943.9% | 13,158 | +583.9% | 0.01% | +700.0% |
Q1 2023 | $41 | -50.6% | 1,924 | -65.9% | 0.00% | -66.7% |
Q4 2022 | $83 | -99.7% | 5,644 | +104.8% | 0.00% | +200.0% |
Q3 2022 | $33,000 | +1000.0% | 2,756 | +530.7% | 0.00% | – |
Q2 2022 | $3,000 | -91.4% | 437 | -91.5% | 0.00% | – |
Q1 2022 | $35,000 | -10.3% | 5,128 | +13.1% | 0.00% | -100.0% |
Q4 2021 | $39,000 | +1200.0% | 4,536 | +1287.2% | 0.00% | – |
Q3 2021 | $3,000 | -88.5% | 327 | -88.1% | 0.00% | -100.0% |
Q2 2021 | $26,000 | +52.9% | 2,742 | +8.1% | 0.00% | – |
Q1 2021 | $17,000 | -58.5% | 2,537 | -57.8% | 0.00% | -100.0% |
Q4 2020 | $41,000 | -65.8% | 6,012 | -71.9% | 0.00% | 0.0% |
Q3 2020 | $120,000 | +1900.0% | 21,385 | +1833.5% | 0.00% | – |
Q2 2020 | $6,000 | -25.0% | 1,106 | -49.0% | 0.00% | – |
Q1 2020 | $8,000 | -87.5% | 2,170 | -73.4% | 0.00% | -100.0% |
Q4 2019 | $64,000 | +300.0% | 8,154 | +183.5% | 0.01% | +400.0% |
Q3 2019 | $16,000 | +166.7% | 2,876 | +341.8% | 0.00% | – |
Q2 2019 | $6,000 | +500.0% | 651 | +225.5% | 0.00% | – |
Q1 2019 | $1,000 | – | 200 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Opaleye Management Inc. | 3,795,000 | $54,534,150 | 17.74% |
Private Capital Management, LLC | 1,416,900 | $20,360,853 | 2.41% |
JACOB ASSET MANAGEMENT OF NEW YORK LLC | 91,779 | $1,318,864 | 1.86% |
Birchview Capital, LP | 150,000 | $2,155,500 | 1.84% |
Diametric Capital, LP | 286,127 | $4,111,644 | 1.72% |
Ophir Asset Management Pty Ltd | 492,179 | $7,072,612 | 1.67% |
BRAIDWELL LP | 1,808,684 | $25,990,789 | 0.82% |
Westside Investment Management, Inc. | 159,019 | $2,285,117 | 0.66% |
INVICTUS PRIVATE WEALTH, LLC | 400,066 | $5,748,948 | 0.63% |
Portolan Capital Management | 385,964 | $5,546,303 | 0.52% |